filings.toolsCover and table of contents
6K characters. Original on sec.gov · Markdown
Cover and table of contents
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, DC 20549
FORM 10-Q
QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d)
OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTER ENDED SEPTEMBER 30, 2022
1-2360
(Commission file number)
INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant as specified in its charter)
| New York | 13-0871985 |
|---|---|
| (State of incorporation) | (IRS employer identification number) |
| | |
| One New Orchard Road Armonk**,** New York | 10504 |
| (Address of principal executive offices) | (Zip Code) |
914**-**499-1900
(Registrant’s telephone number)
Securities registered pursuant to Section 12(b) of the Act:
| Title of each class | Trading symbol(s) | Name of each exchange on which registered | ||
|---|---|---|---|---|
| Capital stock, par value $.20 per share | IBM | New York Stock Exchange | ||
| NYSE Chicago | ||||
| 1.250% Notes due 2023 | IBM 23A | New York Stock Exchange | ||
| 0.375% Notes due 2023 | IBM 23B | New York Stock Exchange | ||
| 1.125% Notes due 2024 | IBM 24A | New York Stock Exchange | ||
| 2.875% Notes due 2025 | IBM 25A | New York Stock Exchange | ||
| 0.950% Notes due 2025 | IBM 25B | New York Stock Exchange | ||
| 0.875% Notes due 2025 | IBM 25C | New York Stock Exchange | ||
| 0.300% Notes due 2026 | IBM 26B | New York Stock Exchange | ||
| 1.250% Notes due 2027 | IBM 27B | New York Stock Exchange | ||
| 0.300% Notes due 2028 | | IBM 28B | | New York Stock Exchange |
| 1.750% Notes due 2028 | IBM 28A | New York Stock Exchange | ||
| 1.500% Notes due 2029 | IBM 29 | New York Stock Exchange | ||
| 0.875% Notes due 2030 | | IBM 30 | | New York Stock Exchange |
| 1.750% Notes due 2031 | IBM 31 | New York Stock Exchange | ||
| 0.650% Notes due 2032 | | IBM 32A | | New York Stock Exchange |
| 1.250% Notes due 2034 | | IBM 34 | | New York Stock Exchange |
| 1.200% Notes due 2040 | | IBM 40 | | New York Stock Exchange |
| 7.00% Debentures due 2025 | IBM 25 | New York Stock Exchange | ||
| 6.22% Debentures due 2027 | IBM 27 | New York Stock Exchange | ||
| 6.50% Debentures due 2028 | IBM 28 | New York Stock Exchange | ||
| 5.875% Debentures due 2032 | | IBM 32D | | New York Stock Exchange |
| 7.00% Debentures due 2045 | IBM 45 | New York Stock Exchange | ||
| 7.125% Debentures due 2096 | IBM 96 | New York Stock Exchange |
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section l3 or l5(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.
| Large accelerated filer ☒ | Accelerated filer ☐ |
|---|---|
| Non-accelerated filer ☐ | Smaller reporting company ☐ |
| | Emerging growth company ☐ |
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act). ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
The registrant had 904,126,363 shares of common stock outstanding at September 30, 2022.
Index
Part I - Financial Information
Next: Item 1. Consolidated Financial Statements: